aXichem’s CEO Torsten Helsing comments on the company’s development in an interview by Västra Hamnen Corporate Finance

aXichem AB (publ) announces that Västra Hamnen Corporate Finance has published an interview with aXichem’s CEO Torsten Helsing (in Swedish) where he comments on the Feed Additive approval for phenylcapsaicin in Brazil and the regulatory status for the product in EU. See the interview here https://youtu.be/LXSYzfPCeS0?si=1sMrcnuMG80dbvZW

The information was submitted, through the care of the contact person below, for publication on 20 December 2023, at 08:30 am CET.

Torsten Helsing, CEO, aXichem, Ph+46 70 686 33 55. Email: torsten.helsing@axichem.se

About aXichem
aXichem develops, patents and markets natural analogue industrial chemicals, i.e., synthetically produced substances that have similar and comparable properties to natural substances. The company's first product is phenylcapsaicin, which the company commercializes under two brands, aXiphen® and aXivite®, as an ingredient in animal feed and dietary supplements, respectively. The business is divided into three market areas with different applications for phenylcapsaicin: as an ingredient in feed for poultry, such as chicken and turkey; as an ingredient in food supplements for gut health, weight control and sports and exercise; and as an ingredient in food supplements for the bio-enhancement of curcumin and melatonin. aXichem is listed on the Nasdaq First North Growth Market. Västra Hamnen Corporate Finance AB is Certified Adviser. More information is available at www.axichem.com.